GSK3B and hepatocellular carcinoma: We demonstrated for the first time that miR-155-5p and CTHRC1 presented an inverse expression pattern in HCC patients and that their functional roles in the development and progression of HCC were exerted by regulating GSK-3β-involved Wnt/β-catenin signaling.